MedPacto Valuation
| 235980 Stock | KRW 4,700 40.00 0.84% |
At this time, the firm appears to be overvalued. MedPacto secures a last-minute Real Value of W3948.0 per share. The latest price of the firm is W4700.0. Our model forecasts the value of MedPacto from analyzing the firm fundamentals such as Return On Equity of -58.54, current valuation of 1.18 T, and Shares Owned By Institutions of 5.45 % as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that MedPacto's price fluctuation is very steady at this time. Calculation of the real value of MedPacto is based on 3 months time horizon. Increasing MedPacto's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since MedPacto is currently traded on the exchange, buyers and sellers on that exchange determine the market value of MedPacto Stock. However, MedPacto's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 4700.0 | Real 3948.0 | Hype 4700.0 | Naive 5063.98 |
The real value of MedPacto Stock, also known as its intrinsic value, is the underlying worth of MedPacto Company, which is reflected in its stock price. It is based on MedPacto's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of MedPacto's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of MedPacto helps investors to forecast how MedPacto stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of MedPacto more accurately as focusing exclusively on MedPacto's fundamentals will not take into account other important factors: MedPacto Total Value Analysis
MedPacto is presently forecasted to have takeover price of 1.18 T with market capitalization of 440.59 B, debt of 75.41 B, and cash on hands of 1.29 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the MedPacto fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.18 T | 440.59 B | 75.41 B | 1.29 B |
MedPacto Asset Utilization
One of the ways to look at asset utilization of MedPacto is to check how much profit was generated for every dollar of assets it reports. MedPacto secures a negative usage of assets of -0.25 %, losing W0.002497 for each won of assets held by the firm. Inadequate asset utilization conveys that the company is being less effective with each won of assets it secures. Strictly speaking, asset utilization of MedPacto shows how discouraging it operates for each won spent on its assets.MedPacto Ownership Allocation
The market capitalization of MedPacto is W440.59 Billion. MedPacto holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Note, that even with negative profits, if the true value of the firm is larger than the current market value, you may still be able to generate positive returns on investment in this company.MedPacto Profitability Analysis
Net Loss for the year was (17.04 B) with loss before overhead, payroll, taxes, and interest of (1.66 M).Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates MedPacto's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in MedPacto and how it compares across the competition.
About MedPacto Valuation
The stock valuation mechanism determines MedPacto's current worth on a weekly basis. Our valuation model uses a comparative analysis of MedPacto. We calculate exposure to MedPacto's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of MedPacto's related companies.MedPacto, Inc., a drug discovery and development company, develops and delivers therapeutics targeting cancer and autoimmune diseases in South Korea. The company is developing ME-1601mAb that targets BSP1 for cancers MS-1601A that targets TRG1 for cancers and autoimmune diseases and vactosertib for solid tumors. MedPacto is traded on Korean Securities Dealers Automated Quotations in South Korea.
8 Steps to conduct MedPacto's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates MedPacto's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct MedPacto's valuation analysis, follow these 8 steps:- Gather financial information: Obtain MedPacto's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine MedPacto's revenue streams: Identify MedPacto's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research MedPacto's industry and market trends, including the size of the market, growth rate, and competition.
- Establish MedPacto's growth potential: Evaluate MedPacto's management, business model, and growth potential.
- Determine MedPacto's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate MedPacto's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Complementary Tools for MedPacto Stock analysis
When running MedPacto's price analysis, check to measure MedPacto's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedPacto is operating at the current time. Most of MedPacto's value examination focuses on studying past and present price action to predict the probability of MedPacto's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedPacto's price. Additionally, you may evaluate how the addition of MedPacto to your portfolios can decrease your overall portfolio volatility.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stocks Directory Find actively traded stocks across global markets |